KIRCIK, L.; SCHLESINGER, T.; ARMSTRONG, A.; BERMAN, B.; BHATIA, N.; DEL ROSSO, J.; LEBWOHL, M.; PATEL, V.; RIGEL, D.; NARAYANAN, S.; KOSCIELNY, V.; KASUJEE, I. Impact of Actinic Keratosis (AK), as measured by patient-reported AK symptoms, and impact on emotions and functioning (using Skindex-16) among patients with AK administered tirbanibulin in real-world community practices across the U.S. (PROAK Study). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s161, 2023. DOI: 10.25251/skin.7.supp.161. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2047. Acesso em: 4 jul. 2024.